507 related articles for article (PubMed ID: 23639599)
1. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
[TBL] [Abstract][Full Text] [Related]
2. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
[TBL] [Abstract][Full Text] [Related]
3. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
[TBL] [Abstract][Full Text] [Related]
5. Methods for diagnosis of bile acid malabsorption in clinical practice.
Vijayvargiya P; Camilleri M; Shin A; Saenger A
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1232-9. PubMed ID: 23644387
[TBL] [Abstract][Full Text] [Related]
6. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
[TBL] [Abstract][Full Text] [Related]
7. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
[TBL] [Abstract][Full Text] [Related]
8. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
[TBL] [Abstract][Full Text] [Related]
9. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
10. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.
Camilleri M; Klee EW; Shin A; Carlson P; Li Y; Grover M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G13-26. PubMed ID: 24200957
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
[TBL] [Abstract][Full Text] [Related]
12. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
[TBL] [Abstract][Full Text] [Related]
13. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
[TBL] [Abstract][Full Text] [Related]
14. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.
Camilleri M; Vazquez-Roque MI; Carlson P; Burton D; Wong BS; Zinsmeister AR
Neurogastroenterol Motil; 2011 Nov; 23(11):995-9, e458. PubMed ID: 21883702
[TBL] [Abstract][Full Text] [Related]
15. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR
Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689
[TBL] [Abstract][Full Text] [Related]
16. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
Camilleri M; Carlson P; Acosta A; Busciglio I
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
[TBL] [Abstract][Full Text] [Related]
17. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions.
Deiteren A; Camilleri M; Bharucha AE; Burton D; McKinzie S; Rao AS; Zinsmeister AR
Neurogastroenterol Motil; 2010 Apr; 22(4):415-23, e95. PubMed ID: 20025675
[TBL] [Abstract][Full Text] [Related]
18. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K
Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
[TBL] [Abstract][Full Text] [Related]
19. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial.
Vijayvargiya P; Camilleri M; Carlson P; Nair A; Nord SL; Ryks M; Rhoten D; Burton D; Busciglio I; Lueke A; Harmsen WS; Donato LJ
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2962-2970.e6. PubMed ID: 32088296
[TBL] [Abstract][Full Text] [Related]
20. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
